Altimmune, Inc. · NASDAQ:ALT
BlackRock, Inc. reported a 7.60% stake in Altimmune, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc. reported a 7.60% stake in Altimmune, Inc., 6,133,427 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 7.60%
- Shares
- 6,133,427
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.60% | 6,133,427 |
Source
Related
- Altimmune, Inc.
- BlackRock, Inc.
- Altimmune, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Weaver Gregory L · Oct 5, 2026
- Form 4 · Arbet-Engels Christophe · Oct 5, 2026
- Form 4 · Richardson Linda M · Sep 17, 2026
- Form 4 · Durso Jerome Benedict · Aug 13, 2026
- Form 4 · Roberts M Scot · Aug 3, 2026